FDA Drug Recalls

Recalls / Class II

Class IID-0414-2024

Product

PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-12, Bar Code 70004081012

Affected lot / code info
Lot #: 1223045536 Exp 12/06/23; 1223045710 Exp 12/10/23; 1223046574 Exp 01/12/24; 1223047579 Exp 02/21/24; 1223047764 Exp 03/06/24; 1223048363 Exp 03/30/24; 1223048364 Exp 03/30/24; 1223048566 Exp 04/06/24; 1223048573 Exp 04/07/24; 1223048574 Exp 04/07/24; 1223048643 Exp 04/11/24; 1223048697 Exp 04/12/24; 1223048742 Exp 04/13/24 Expanded lots#: 1223048065, Exp 04/06/2024; 1223048395, 1223048397, Exp 03/27/2024; 1223049980, Exp 06/05/2024

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
SCA Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, N/A, Windsor, Connecticut 06095-1024

Distribution

Quantity
33,072 syringes; expanded 9,041 syringes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-11-09
FDA classified
2024-03-22
Posted by FDA
2024-04-03
Terminated
2024-08-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0414-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls